Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2021-09-07 2021-09-07
Drug Identification Number 02410397 02410397
Brand name DOXORUBICIN DOXORUBICIN
Common or Proper name DOXORUBICIN DOXORUBICIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients DOXORUBICIN HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVESICAL INTRAVENOUS INTRAVESICAL INTRAVENOUS INTRAVESICAL INTRAVENOUS INTRAVESICAL INTRAVENOUS
Packaging size 1 x 100mL 1 x 100mL
ATC code L01DB L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-08-25 2021-08-25
Remaining supply date 2021-08-25 2021-08-25
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments